Bank of New York Mellon’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.02M | Buy |
|
|||||
|
2025
Q2 | $1.95M | Buy |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $1.52M | Buy |
|
|||||
|
2024
Q3 | $1.34M | Sell |
|
|||||
|
2024
Q2 | $1.78M | Buy |
|
|||||
|
2024
Q1 | $3.19M | Buy |
|
|||||
|
2023
Q4 | $3M | Buy |
|
|||||
|
2023
Q3 | $924K | Buy |
|
|||||
|
2023
Q2 | $899K | Buy |
|
|||||
|
2023
Q1 | $211K | Sell |
|
|||||
|
2022
Q4 | $280K | Buy |
|
|||||
|
2022
Q3 | $612K | Buy |
|
|||||
|
2022
Q2 | $550K | Sell |
|
|||||
|
2022
Q1 | $966K | Buy |
|
|||||
|
2021
Q4 | $923K | Buy |
|
|||||
|
2021
Q3 | $747K | Buy |
|
|||||
|
2021
Q2 | $530K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $14K | Hold |
|
|||||
|
2020
Q2 | $21K | Sell |
|
|||||
|
2020
Q1 | $175K | Buy |
|
|||||
|
2019
Q4 | $249K | Sell |
|
|||||
|
2019
Q3 | $297K | Buy |
|
|||||
|
2019
Q2 | $245K | Buy |
|
|||||
|
2019
Q1 | $82K | Sell |
|
|||||
|
2018
Q4 | $97K | Buy |
|
|||||
|
2018
Q3 | $103K | Hold |
|
|||||
|
2018
Q2 | $60K | Sell |
|
|||||
|
2018
Q1 | $43K | Buy |
|
|||||
|
2017
Q4 | $31K | Buy |
|
|||||
|
2017
Q3 | $35K | Hold |
|
|||||
|
2017
Q2 | $49K | Sell |
|
|||||
|
2017
Q1 | $52K | Buy |
|
|||||
|
2016
Q4 | $49K | Sell |
|
|||||
|
2016
Q3 | $156K | Sell |
|
|||||
|
2016
Q2 | $163K | Buy |
|
|||||
|
2016
Q1 | $154K | Buy |
|
|||||
|
2015
Q4 | $174K | Sell |
|
|||||
|
2015
Q3 | $231K | Buy |
|
|||||
|
2015
Q2 | $239K | Buy |
|
|||||
|
2015
Q1 | $229K | Sell |
|
|||||
|
2014
Q4 | $240K | Buy |
|
|||||
|
2014
Q3 | $139K | Hold |
|
|||||
|
2014
Q2 | $137K | Buy |
|
|||||
|
2014
Q1 | $129K | Buy |
|
|||||
|
2013
Q4 | $109K | Sell |
|
|||||
|
2013
Q3 | $118K | Buy |
|
|||||
|
2013
Q2 | $108K | Buy |
|